Categories
Latest Industry Intelligence
As the world is rocked by one of the greatest healthcare challenges in living memory, [...]
Luis Valente, CEO & Co-Founder of iLoF, has been recognized by Forbes as one of [...]
Lu Rahman looks at the drug repurposing market. How attractive a proposition is it financially? More than ever the world is watching drug development and is aware of the time [...]
With COVID-19 taking centre stage in global drug discovery, Lu Rahman looks at opportunities ahead for the sector and where attention might be focussed going forward. It is clear from [...]
As the world is rocked by one of the greatest healthcare challenges in living memory, how we treat infectious diseases is becoming one of the key medical questions of our [...]
CRO opens new Oxford site in response to urgent demand from small and medium innovators for specialist scientific expertise. Europital – the global provider of medical management services for clinical [...]
SPT Labtech recently opened a new office to maximise on Japanese biotech growth. Lu Rahman caught up with Director Masahiro Matsushita, to find out about the region and the opportunities [...]
Lu Rahman looks at how opportunities are growing in Japanese drug development and where innovation is coming from. Japan is a fascinating drug discovery and development market. A strong pharmaceutical [...]
Advancements in technology, and in particular, developments in artificial intelligence (AI) are revolutionising the way that we live our lives. Up to now, we have used it to help us [...]
The Personalized Medicine Coalition The Personalized Medicine Coalition (PMC), representing a broad spectrum of academic, industrial, patient, provider, and payer communities, seeks to advance the understanding and adoption of personalized [...]
Collaborative Research Leads To New Understanding Of Biomarkers By Dr Max Ryadnov and Professor Jason Crain A new collaborative research paper sheds light on the way antibodies distinguish between different [...]
Guidelines & Recommendations For Analyzing and Interpreting GPCR Second Messenger Data Sponsored by CisBio The question of choosing which methods to use for analyte quantification (signal vs concentration determination, parameters, [...]
Menu ≡ ╳ 
